Search
Caribou Biosciences Inc
CRBUAdd to Watchlist
1.460USD
-0.050-3.31%
Close 07-31 16:00（ET）Quotes delayed by 15 min
144.80MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Caribou Biosciences Inc is 8.75, ranking 61 out of 385 in the Biotechnology & Medical Research industry. The average price target is 8.50, with a high of 32.00 and a low of 4.00.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
12.125
Target Price
+724.83%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Caribou Biosciences Inc
CRBU
8
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Caribou Biosciences Inc's expected revenue for the next quarter?
Caribou Biosciences Inc's expected revenue is 2.28M.
What is Caribou Biosciences Inc's price target?
Analysts forecast that Caribou Biosciences Inc's price target is USD 8.50, with the highest forecast at USD 32.00 and the lowest forecast at USD 4.00.
How have Caribou Biosciences IncCRBU's recent earnings per share performed?
The market expectation was USD -0.26, while Caribou Biosciences IncCRBU's earnings per share (EPS) for the previous quarter was USD -0.28. EPS for the next quarter is expected at USD -0.32.
What is the analyst rating for Caribou Biosciences Inc?
Based on the ratings of Caribou Biosciences Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.